Literature DB >> 1689482

The prostate: an increasing medical problem.

H B Carter1, D S Coffey.   

Abstract

The prostate gland is the major site of medical problems in the U.S. male. Surgery for benign prostatic hyperplasia is the most common surgical procedure performed in males, and the total cost for this surgery exceeds 1 billion dollars per year. The incidence of and mortality from prostate cancer are increasing yearly. Prostate cancer now exceeds lung cancer as the most commonly diagnosed cancer in males and is the second leading cause of male cancer deaths. Of all tumors, the prevalence of prostate cancer increases the most rapidly with age. A shift in age distribution favoring an older population will lead to an increase in the number of patients diagnosed with prostate cancer in the United States. It is estimated that by the year 2000 there will be a 37% increase in prostate cancer deaths per year and a 90% increase in prostate cancer cases per year. Although the factors responsible for the development and progression of prostate cancer to a clinically manifest form are not known, there is evidence that environmental factors may play a role. It will be important for the future to focus on the etiological factors that may lead to a decrease in the prevalence of prostatic tumors.

Entities:  

Mesh:

Year:  1990        PMID: 1689482     DOI: 10.1002/pros.2990160105

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  47 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Screening for prostate cancer using multivariate mixed-effects models.

Authors:  Christopher H Morrell; Larry J Brant; Shan Sheng; E Jeffrey Metter
Journal:  J Appl Stat       Date:  2012-06-01       Impact factor: 1.404

3.  Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.

Authors:  Vladimir Zaichick; Sofia Zaichick
Journal:  Age (Dordr)       Date:  2013-07-14

4.  Acoustic radiation force impulse imaging of human prostates ex vivo.

Authors:  Liang Zhai; John Madden; Wen-Chi Foo; Mark L Palmeri; Vladimir Mouraviev; Thomas J Polascik; Kathryn R Nightingale
Journal:  Ultrasound Med Biol       Date:  2010-04       Impact factor: 2.998

5.  Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells.

Authors:  Dae-Hee Lee; Clifford Kim; Lin Zhang; Yong J Lee
Journal:  Biochem Pharmacol       Date:  2008-02-29       Impact factor: 5.858

Review 6.  Comparison of the cost-effectiveness of various therapies for common prostatic disorders.

Authors:  E A Amin; M Amin
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

7.  PALB2 variants in hereditary and unselected Finnish prostate cancer cases.

Authors:  Sanna Pakkanen; Tiina Wahlfors; Sanna Siltanen; Mimmi Patrikainen; Mika P Matikainen; Teuvo L J Tammela; Johanna Schleutker
Journal:  J Negat Results Biomed       Date:  2009-12-15

8.  Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.

Authors:  Kevin Shoulars; Mary Ann Rodriguez; Trellis Thompson; Barry M Markaverich
Journal:  J Steroid Biochem Mol Biol       Date:  2009-10-27       Impact factor: 4.292

Review 9.  The safety of vasectomy: recent concerns.

Authors:  T M Farley; O Meirik; S Mehta; G M Waites
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

10.  Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.

Authors:  M Tanaka; K Fujimoto; Y Chihara; K Torimoto; T Yoneda; N Tanaka; A Hirayama; N Miyanaga; H Akaza; Y Hirao
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-07-14       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.